Skip to content

eNose-TB: Electronic Nose for Tuberculosis Screening

eNose-TB: Electronic Nose for Tuberculosis Screening in Indonesia

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04567498
Enrollment
1778
Registered
2020-09-28
Start date
2021-12-02
Completion date
2024-12-31
Last updated
2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

electronic-nose, breath test, tuberculosis, screening, gender, remote area

Brief summary

An electronic-nose (e-nose) is being investigated as a diagnostic tool for tuberculosis by examining exhaled breath of the patients. Universitas Gadjah Mada has developed an e-nose device for TB diagnostic tool. Here the investigators test the device in order to analyze the sensitivity and specificity electronic-nose as a screening tool for tuberculosis particularly in remote area. Various factors (gender, age, race, and location) are considered in the algorithm training to develop an inclusive eNose. Access barriers, especially those faced by women, are also assessed.

Detailed description

The study population consists of 2 groups: Group 1 - presumptive TB patients. Group 2 - residents of area with high risk of TB. Study participants provide written informed consent. The participants are asked to breathe normally using a mask for 2 times then inhale and exhale in a forced expiratory volume to the air collecting bag until the collecting bag is full (two times). The collecting bag is sealed and connected to the e-nose machine via a collecting hose and HEPA-filter protecting the e-nose from microbes. The breath pattern will be recorded in the e-nose device, which is connected to a laptop that will display the recorded breath pattern. Other data are collected: clinical symptoms, results of chest X-ray, smear microscopic, and Xpert MTB/Rif examinations. Demographic (gender, age, race, and location) and clinical data (symptoms, physical examination, laboratory examinations) are collected. Access barriers, especially for women, are also assessed through questionnaire and interviews.

Interventions

The participants are requested to quietly sit and breathe to the air collecting bag until the collecting bag is full. The collecting bag is sealed and connected to the e-nose machine via a collecting hose and HEPA-filter. The data are read and stored in the e-nose machine.

Sponsors

Gadjah Mada University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Masking description

The research subjects, breath sample takers, and laboratory sample examiners do not know the results of each sampling that has been done. The final data processor is also blinded to the results of Xpert or other laboratory examinations. The breath sampling data is saved in graphic form which interpretation will be carried out later by the data processor at the final stage.

Intervention model description

The Validation phase involves presumptive TB patients (Group 1) and the Screening phase involves residents of area with high risk of TB (Group 2)

Eligibility

Sex/Gender
ALL
Age
4 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Inclusion Criteria: Validation Phase (Group 1): * Adult and children * Suspected of having TB * Agree to participate in the study * Able to produce exhaled air samples * Able to produce samples for Xpert MTB/Rif examination Screening Phase (Group 2): * Adult and children * Agree to participate in the study * Able to produce exhaled air samples * Currently not in TB treatment \-

Exclusion criteria

* Invalid measurements of breath tests * Incomplete CXR data * Missing specimens * Unable to breath normally for 2 minutes due to respiratory illness

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy of electronic nose signal in screening tuberculosis that is measured through sensitivity, specificity, PPV, NPV2 yearssensitivity, specificity, positive predictive value, negative predictive value of e-nose signal in diagnosing TB, factors influencing the diagnostic accuracy
Access barriers, measured through questionnaire, interview, and focus group discussion2 yearsaccess barriers to the TB screening that are measured through questionnaire, interview, and focus group discussion

Secondary

MeasureTime frameDescription
Time of a screening algorithm with eNose-TB, measured in days2 yearsTime of a screening algorithm with eNose-TB to obtain additional detection of one TB case, measured in days

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026